VIP was proposed as a biomarker for inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis in a study reporting elevated VIP plasma concentrations during the active inflammatory disease phase97. This evidence concerns the gene VIP and ulcerative colitis.